Biorepository for cardiovascular and metabolic disease research
Vascular Lab Resource (VLR) Biorepository Study
This study is collecting blood, urine, and stool samples from people with heart and metabolic diseases to help researchers better understand these conditions and improve care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Trial ID | NCT05628948 on ClinicalTrials.gov |
What this trial studies
This initiative focuses on collecting and analyzing biomarkers from blood, urine, and stool samples of subjects with cardiovascular and metabolic diseases. It aims to create a biorepository that facilitates collaboration between clinicians and basic scientists at the Cleveland Clinic Main Campus and the Lerner Research Institute. By leveraging this resource, the study seeks to enhance research on vascular diseases and improve understanding of their underlying mechanisms. The goal is to address the fragmented care and under-researched nature of these conditions.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 18 and older who are diagnosed with or at risk for cardiovascular and metabolic diseases.
Not a fit: Patients with a known life expectancy of six months or less, current pregnancy, or severe anemia may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to improved diagnostic and therapeutic strategies for patients with cardiovascular and metabolic diseases.
How similar studies have performed: Other studies utilizing biorepositories for similar conditions have shown promise in advancing research and improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years or older 2. Subjects capable of providing informed consent document 3. Subjects with diagnosed with or at risk for cardiovascular and metabolic diseases Exclusion Criteria: 1. Known life expectancy of ≤ 6 months at the time of enrollment 2. Known current pregnancy 3. Severe Anemia (last documented hemoglobin \< 7.0 g/dL)
Where this trial is running
Cleveland, Ohio
- Cleveland Clinic — Cleveland, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Scott Cameron, MD, PhD — The Cleveland Clinic
- Study coordinator: Scott Cameron, MD, PhD
- Email: cameros3@ccf.org
- Phone: 216-444-1680
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.